Seno Medical Instruments senomedical.com


Public lists: Medical Devices (6162)

Seno Medical was formed to commercialize a new modality in cancer screening and diagnosis: laser opto-acoustic imaging. Unlike most screening techniques, which rely on anatomical imaging, Seno's goal is to bring functional imaging that can detect angiogenesis to the marketplace. Products for use with humans, focusing initially on breast cancer, are also in development for subsequent testing. Seno's patented technology integrates the use of lasers and acoustics to determine the presence of angio...Show all

Seno Medical was formed to commercialize a new modality in cancer screening and diagnosis: laser opto-acoustic imaging. Unlike most screening techniques, which rely on anatomical imaging, Seno's goal is to bring functional imaging that can detect ang...Show all

Company (Alive / Active)

Phone: 210-615-6501

Fax:

5253 Prue Road
Suite 315
San Antonio, 78240
Texas, United States

Latest News

See more competitors data Competitors
Total Funding Date of Last Funding
Seno Medical Instruments $63.8M Feb 18, 2014
See all 24 competitors

Web Traffic

Rank

Show (-10)

Engagement (PVPU)

Show (+1%)

Domain Authority Score
Show
Page Views Per Million (PVPM)
Show
Reach Per Million
Show

SEO Statistics

Domain Authority Score Show
Page Authority Score Show
No. External Links Show
No. Links Show

Web Traffic Statistics - Growth

Per Week Per Month Per 6 Months Per Year
Rank Login to see details
Page Views Per Million Login to see details
Page Views Per User Login to see details
Reach Per Million Login to see details

Related Seno Medical Instruments Jobs

jobs by Indeed job
						search

Investors

Investor Investor Type Location Participating Rounds
See all 5 investors

Competitors

Company Status Description Investors

Cellpoint Diagnostics

La Jolla, California, United States
Alive / ActiveCellPoint Diagnostics is developing diagnostic, monitoring, and molecular analytical tools for cancer. Its technology captures and analyzes circulating tumor cells ("CTCs") directly from patient blood. Scientific and clinical data have demonstrated that CTCs are derived from the primary tumor, and the assessment of the number of CTCs in the blood has been shown to accurately predict survival for cancer patients.Login to see details

Tripath Imaging (fka Autocyte)

Burlington, North Carolina, United States
Alive / ActiveTripath Imaging (fka Autocyte) offers cervical cancer screening systemsLogin to see details
See all 24 competitors

Patents

Title Application Date Patent Date Status
(Patent / Application)
Statistical mapping in an optoacoustic imaging system May 03, 2016 Dec 05, 2017 Patent
Noise suppression in an optoacoustic system Mar 15, 2013 Nov 14, 2017 Patent
System and method for acquiring optoacoustic data and producing parametric maps using subband acoustic compensation Nov 17, 2016 Oct 17, 2017 Patent
Method for dual modality optoacoustic imaging Nov 02, 2012 Sep 12, 2017 Patent
Playback mode in an optoacoustic imaging system Mar 15, 2013 Aug 29, 2017 Patent
See all 56 patents